Skip to main content
Back to Show
PBS News Hour

What’s keeping biosimilar drugs from the U.S. market?

NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.

Support Provided By
Season
September 27, 2025 - PBS News Weekend full episode
26:45
September 27, 2025 - PBS News Weekend full episode
September 26, 2025 - PBS News Hour full episode
57:46
September 26, 2025 - PBS News Hour full episode
September 25, 2025 - PBS News Hour full episode
57:46
September 25, 2025 - PBS News Hour full episode
September 24, 2025 - PBS News Hour full episode
56:45
September 24, 2025 - PBS News Hour full episode
September 23, 2025 - PBS News Hour full episode
56:50
September 23, 2025 - PBS News Hour full episode
September 22, 2025 - PBS News Hour full episode
57:46
September 22, 2025 - PBS News Hour full episode
September 21, 2025 - PBS News Weekend full episode
26:45
September 21, 2025 - PBS News Weekend full episode
September 20, 2025 - PBS News Weekend full episode
26:45
September 20, 2025 - PBS News Weekend full episode
September 19, 2025 - PBS News Hour full episode
57:46
September 19, 2025 - PBS News Hour full episode
September 18, 2025 - PBS News Hour full episode
57:46
September 18, 2025 - PBS News Hour full episode
September 17, 2025 - PBS News Hour full episode
57:46
September 17, 2025 - PBS News Hour full episode
September 16, 2025 - PBS News Hour full episode
57:46
September 16, 2025 - PBS News Hour full episode
Active loading indicator